Literature DB >> 10741083

Behavioral treatment of insomnia: the Wilford Hall Insomnia Program.

A S Hryshko-Mullen1, L S Broeckl, C K Haddock, A L Peterson.   

Abstract

Persistent insomnia is one of the most common patient complaints reported in primary care settings. This paper reviews the behavioral assessment and treatment approaches for persistent insomnia and reports the results of 42 consecutively treated patients in the Wilford Hall Insomnia Program. Patients were treated in a six-session, multiple-component behavioral group treatment program consisting of sleep restriction, stimulus control, sleep hygiene, relaxation training, and cognitive therapy. In addition, patients were seen for two individual treatment sessions in conjunction with the program and for two individual post-group treatment sessions to assess treatment progress. The results indicated that sleep onset latency was improved by 53%, wake after sleep onset was decreased by 40%, and sleep efficiency was improved by 22%. A detailed description of the behavioral treatment program for insomnia is provided as well as recommendations for practitioners working in primary care settings.

Entities:  

Mesh:

Year:  2000        PMID: 10741083

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  3 in total

Review 1.  Abuse-deterrent and tamper-resistant opioid formulations: what is their role in addressing prescription opioid abuse?

Authors:  Jennifer P Schneider; Michele Matthews; Robert N Jamison
Journal:  CNS Drugs       Date:  2010-10       Impact factor: 5.749

Review 2.  Sleep problems in the child with attention-deficit hyperactivity disorder: defining aetiology and appropriate treatments.

Authors:  Margaret D Weiss; Jay Salpekar
Journal:  CNS Drugs       Date:  2010-10       Impact factor: 5.749

3.  Sleep and military members: emerging issues and nonpharmacological intervention.

Authors:  Cary A Brown; Robyn Berry; Ashley Schmidt
Journal:  Sleep Disord       Date:  2013-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.